Placentation abnormalities in the pathophysiology of preeclampsia

References

• van Lerberghe W; World Health Organization. World health report: make every mother and child count. World Health Organization, Geneva (2005).
   Google Scholar
• Marin R, Gorostidi M, Portal CG et al. Long-term prognosis of hypertension in pregnancy. Hypertens. Pregnancy19(2), 199–209 (2000).
   PubMed Web of Science ®Google Scholar
• Duckitt K, Harrington D. Risk factors for preeclampsia at antenatal booking: systemic review of controlled studies. BMJ330(7491), 565–571 (2005).
   PubMed Web of Science ®Google Scholar
• Mazar RM, Srinivas SK, Sammel MD et al. Metabolic score as a novel approach to assessing preeclampsia risk. Am. J. Obstet. Gynecol.197(4), 411 e1–e5 (2007).
   Google Scholar
• Loi K, Khoo CK, Tan KH et al. A review of 93 cases of severe preeclampsia in Singapore: are there risk factors for complications? Singapore Med. J.48(9), 808–812 (2007).
   Google Scholar
• Silver RK, Wilson RD, Philip J et al. Late first-trimester placental disruption and subsequent gestational hypertension/preeclampsia. Obstet. Gynecol.105(3), 587–592 (2005).
   PubMed Web of Science ®Google Scholar
• Haelterman E, Marcoux S, Croteau A et al. Population-based study on occupational risks for preeclampsia and gestational hypertension. Scand. J. Work Environ. Health33(4), 304–317 (2007).
   PubMed Web of Science ®Google Scholar
• ACOG Committee on Obstetric Practice. Diagnosis and management of preeclampsia and eclampsia. ACOG Practice Bulletin No. 33 American College of Obstetricians and Gynecologists. Obstet. Gynecol.99(1), 159–167 (2002).
   PubMed Web of Science ®Google Scholar
• Sibai BM. Imitators of severe preeclampsia. Obstet. Gynecol.109(4), 956–966 (2007).
   PubMed Web of Science ®Google Scholar
• Sibai BM. Diagnosis and management of gestational hypertension and preeclampsia. Obstet. Gynecol.102(1), 181–192 (2003).
   PubMed Web of Science ®Google Scholar
• Zhou Y, Fisher SJ, Janatpour M et al. Human cytotrophoblasts adopt a vascular phenotype as they differentiate. A strategy for successful endovascular invasion? J. Clin. Invest.99(9), 2139–2151 (1997).
   PubMed Web of Science ®Google Scholar
• Kaufmann P, Black S, Huppertz B. Endovascular trophoblast invasion: implications for the pathogenesis of intrauterine growth retardation and preeclampsia. Biol. Reprod.69(1), 1–7 (2003).
   PubMed Web of Science ®Google Scholar
• Dahlstrom B, Romundstad P, Oian P et al. Placenta weight in pre-eclampsia. Acta Obstet. Gynecol. Scand.87(6), 608–611 (2008).
   PubMed Web of Science ®Google Scholar
• Daayana S, Baker P, Crocker I. An image analysis technique for the investigation of variations in placental morphology in pregnancies complicated by preeclampsia with and without intrauterine growth restriction. J. Soc. Gynecol. Investig.11(6), 545–552 (2004).
   PubMedGoogle Scholar
• Kos M, Czernobilsky B, Hlupic L, Kunjko K. Pathological changes in placentas from pregnancies with preeclampsia and eclampsia with emphasis on persistence of endovascular trophoblastic plugs. Croat. Med. J.46(3), 404–409 (2005).
   Google Scholar
• Redline RW, Patterson P. Pre-eclampsia is associated with an excess of proliferative immature intermediate trophoblast. Hum. Pathol.26(6), 594–600 (1995).
   PubMed Web of Science ®Google Scholar
• Robertson WB, Brosens IA, Dixon HG. Placental bed vessels. Am. J. Obstet Gynecol.117(2), 294–295 (1973).
   Google Scholar
• Lain KY, Roberts JM. Contemporary concepts of the pathogenesis and management of preeclampsia. JAMA287(24), 3183–3186 (2002).
   PubMed Web of Science ®Google Scholar
• Redman CWG, Sargent IL. Pre-eclampsia, the placenta and the maternal systemic inflammatory response – a review. Placenta17(Suppl. A), S21–S27 (2003).
   Google Scholar
• Stanek J, Weng E. Microscopic chorionic pseudocysts in placental membranes a histologic lesion of in utero hypoxia. Pediatr. Dev. Pathol.10(3), 192–198 (2007).
   Google Scholar
• Langbein M, Strick R, Strissel PL et al. Impaired cytotrophoblast cell–cell fusion is associated with reduced syncytin and increased apoptosis in patients with placental dysfunction. Mol. Reprod. Dev.75(1), 175–183 (2008).
   PubMed Web of Science ®Google Scholar
• Richani K, Romero R, Soto E et al. Genetic origin and proportion of basal plate surface-lining cells in normal and abnormal pregnancies. Hum. Pathol.38(2), 269–275 (2007).
   Google Scholar
• Smith RK, Ockleford CD, Byrne S, Bosio P, Sanders R. Healthy and pre-eclamptic placental basal plate lining cells: quantitative comparisons based on confocal laser scanning microscopy. Microsc. Res. Tech.64(1), 54–62 (2004).
   Google Scholar
• Ockleford CD, Smith RK, Byrne S, Sanders R, Bosio P. Confocal laser scanning microscope study of cytokeratin immunofluorescence differences between villus and extravillous trophoblast: cytokeratin downregulation in preeclampsia. Microsc. Res. Tech.64(1), 43–53 (2004).
   Google Scholar
• Resta L, Capobianco C, Marzullo A et al. Confocal laser scanning microscope study of terminal villi vessels in normal term and pre-eclamptic placentas. Placenta27(6–7), 735–739 (2006).
   Google Scholar
• Mayhew TM, Charnock-Jones DS, Kaufmann P. Aspects of human fetoplacental vasculogenesis and angiogenesis. III. Changes in complicated pregnancies. Placenta25(2–3), 127–139 (2004).
   PubMed Web of Science ®Google Scholar
• Mayhew TM, Wijesekara J, Baker PN, Ong SS. Morphometric evidence that villus development and fetoplacental angiogenesis are compromised by intrauterine growth restriction but not by preeclampsia. Placenta25(10), 829–833 (2004).
   PubMed Web of Science ®Google Scholar
• Egbor M, Ansari T, Morris N, Green CJ, Sibbons PD. Pre-eclampsia and fetal growth restriction: how morphometrically different is the placenta? Placenta27(6–7), 727–734 (2006).
   PubMed Web of Science ®Google Scholar
• Egbor M, Ansari T, Morris N, Green CJ, Sibbons PD. Morphometric placental villus and vascular abnormalities in early- and late-onset pre-eclampsia with and without fetal growth restriction. BJOG113(5), 580–589 (2006).
   PubMed Web of Science ®Google Scholar
• Vinnars MT, Wijnaendts LC, Westgren M, Bolte AC, Papadogiannakis N, Nasiell J. Severe preeclampsia with and without HELLP differ with regard to placental pathology. Hypertension51(5), 1295–1299 (2008).
   PubMed Web of Science ®Google Scholar
• Reister F, Frank HG, Kingdom JC et al. Macrophage-induced apoptosis limits endovascular trophoblast invasion in the uterine wall of preeclamptic women. Lab. Invest.81(8), 1143–1152 (2001).
   PubMed Web of Science ®Google Scholar
• Abrahams VM, Kim YM, Straszewski SL et al. Macrophages and apoptotic cell clearance during pregnancy. Am. J. Reprod. Immnol.51(4), 275–282 (2004).
   PubMed Web of Science ®Google Scholar
• Katabuchi H, Yih S, Ohba T et al. Characterization of macrophages in the decidual atherotic spiral artery with special reference to the cytology of foam cells. Med. Electron Microsc.36(4), 253–262 (2003).
   PubMedGoogle Scholar
• Hayashi M, Hoshimoto K, Ohkura T, Inaba N. Increased levels of macrophage colony-stimulating factor in the placenta in the placenta and blood in preeclampsia. Am. J. Reprod. Immunol.47(1), 19–24 (2002).
   Google Scholar
• Lockwood CJ, Matta P, Krikun G et al. Regulation of monocyte chemoattractant protein-1 expression by tumor necrosis factor- and interleukin-1 in first trimester human decidual cells. Am. J. Pathol.168(2), 445–452 (2006).
   PubMed Web of Science ®Google Scholar
• Renaud SJ, Graham CH. The role of macrophages in utero-placental interactions during normal and pathological pregnancy. Immunol. Invest.37(5), 535–564 (2008).
   PubMed Web of Science ®Google Scholar
• Huang SJ, Chen CP, Schatz F, Rahman M, Abrahams VM, Lockwood CJ. Pre-eclampsia is associated with dendritic cell recruitment into the uterine deciduas. J. Pathol.214(3), 328–336 (2008).
   PubMed Web of Science ®Google Scholar
• Hiby SE, Walker JJ, O’shaughnessy KM et al. Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J. Exp. Med.200(8), 957–965 (2004).
   PubMed Web of Science ®Google Scholar
• Ballermann BJ. Glomerular endothelial cell differentiation. Kidney Int.67(5), 1668–1671 (2005).
   PubMed Web of Science ®Google Scholar
• Maharaj AS, Saint-Geniez M, Maldonado AE, D’Amore PA. Vascular endothelial growth factor localization in the adult. Am. J. Pathol.168(2), 639–648 (2006).
   PubMed Web of Science ®Google Scholar
• Eremina V, Sood M, Haigh J et al. Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. J. Clin. Invest.111(5), 707–716 (2003).
   PubMed Web of Science ®Google Scholar
• Sugimoto H, Hamano Y, Charytan D et al. Neutralization of circulating vascular endothelial growth factor (VEGF) by anti-VEGF antibodies and soluble VEGF receptor 1 (sFlt1) induces proteinuria. J. Biol. Chem.278(15), 12605–12608 (2003).
   PubMed Web of Science ®Google Scholar
• Cirpan T, Akercan F, Terek MC et al. Evaluation of VEGF in placental bed biopsies from preeclamptic women by immunohistochemistry. Clin. Exp. Obstet. Gynecol.34(4), 228–231 (2007).
   PubMed Web of Science ®Google Scholar
• Akercan F, Cirpan T, Terek MC et al. The immunohistochemical evaluation of VEGF in placenta biopsies of pregnancies complicated by preeclampsia. Arch. Gynecol. Obstet.277(2), 109–114 (2008).
   PubMed Web of Science ®Google Scholar
• Cobellis L, Mastrogiacomo A, Federico E et al. Distribution of Notch protein members in normal and preeclampsia-complicated placentas. Cell Tissue Res.330(3), 527–534 (2007).
   PubMed Web of Science ®Google Scholar
• Gu Y, Lewis DF, Wang Y. Placental productions and expressions of soluble endoglin, soluble fms-like tyrosine kinase receptor-1, and placental growth factor in normal and preeclamptic pregnancies. J. Clin. Endocrinol. Metab.93(1), 260–266 (2008).
   PubMed Web of Science ®Google Scholar
• Maynard SE, Min JY, Merchan J et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension and proteinuria in preeclampsia. J. Clin. Invest.111(5), 649–658 (2003).
   PubMed Web of Science ®Google Scholar
• Ahmad S, Ahmed A. Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia. Circ. Res.95(9), 884–891 (2004).
   PubMed Web of Science ®Google Scholar
• Nagamatsu T, Fujii T, Kusumi M et al. Cytotrophoblasts up-regulate soluble fms-like tyrosine kinase-1 expression under reduced oxygen: an implication for the placental vascular development and the pathophysiology of preeclampsia. Endocrinology145(11), 4838–4845 (2004).
   PubMed Web of Science ®Google Scholar
• Munaut C, Lorquet S, Pequeux C et al. Hypoxia is responsible for soluble vascular endothelial growth factor receptor-1 (VEGFR-1) but nor for soluble endoglin induction in villus trophoblast. Hum. Reprod.23(6), 1407–1415 (2008).
   PubMed Web of Science ®Google Scholar
• Zhou Y, McMaster M, Woo K et al. Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome. Am. J. Pathol.160(4), 1405–1423 (2002).
   PubMed Web of Science ®Google Scholar
• Zhou CC, Ahmad S, Mi T et al. Angiotensin II induces soluble fms-like tyrosine kinase-1 release via calcineurin signaling pathway in pregnancy. Circ. Res.100(1), 88–95 (2007).
   PubMed Web of Science ®Google Scholar
• Li H, Gu B, Zhang Y et al. Hypoxia-induced increase in soluble Flt-1 production correlates with enhanced oxidative stress in trophoblast cells from the human placenta. Placenta26(2–3), 210–217 (2005).
   PubMed Web of Science ®Google Scholar
• Rajakumar A, Brandon HM, Daftary A et al. Evidence for the functional activity of hypoxia-inducible transcription factors overexpressed in preeclamptic placentae. Placenta25(10), 763–769 (2004).
   PubMed Web of Science ®Google Scholar
• Chaouat G, Ledée-Bataille N, Dubanchet S. Immune cells in uteroplacental tissues throughout pregnancy: a brief review. Reprod. Biomed. Online14(2), 256–266 (2007).
   PubMed Web of Science ®Google Scholar
• Bauer S, Pollheimer J, Hartmann J, Husslein P, Aplin JD, Knofler M. Tumor necrosis factor-α inhibits trophoblast migration through elevation of plasminogen activator inhibitor-1 in first trimester villus explants cultures. J. Clin. Endocrinol. Metab.89(2), 812–822 (2004).
   PubMed Web of Science ®Google Scholar
• Hayashi M, Ueda Y, Yamaguchi T et al. Tumor necrosis factor-α in the placenta is not elevated in pre-eclamptic patients despite its elevation in peripheral blood. Am. J. Reprod. Immunol.53(3), 113–119 (2005).
   PubMed Web of Science ®Google Scholar
• Hung TH, Charnock-Jones DS, Skepper JN, Burton GJ. Secretion of tumor necrosis factor- from human placental tissues induced by hypoxia-reoxygenation causes endothelial cell activation in vitro. Am. J. Pathol.164(3), 1049–1061 (2004).
   PubMed Web of Science ®Google Scholar
• Crocker IP, Cooper S, Ong SC, Baker PN. Differences in apoptotic susceptibility of isolated cytotrophoblasts and syncytiotrophoblasts in pregnancy to those complicated with preeclampsia and intrauterine growth restriction. Am. J. Pathol.162(2), 637–643 (2003).
   PubMed Web of Science ®Google Scholar
• Kharfi A, Bureau M, Giguere Y, Moutquin JM, Forest JC. Dissociation between increased apoptosis and expression of the tumor necrosis factor-α system in term placental villi with preeclampsia. Clin. Biochem.39(6), 646–651 (2006).
   Google Scholar
• Crocker IP, Tansinda DM, Baker PN. Altered cell kinetics in cultured placental villus explants in pregnancies complicated by pre-eclampsia and intrauterine growth restriction. J. Pathol.204(1), 11–18 (2004).
   PubMed Web of Science ®Google Scholar
• Kwaan HC, Wang J, Boggio L Weiss I, Grobman W. The thrombogenic effect of an inflammatory cytokine on trophoblasts from women with preeclampsia. Am. J. Obstet. Gynecol.191(6), 2142–2147 (2004).
   PubMedGoogle Scholar
• Seki H, Matuoka K, Inooku H, Takeda S. TNF-α from monocyte of patients with pre-eclampsia-induced apoptosis in human trophoblast cell line. J. Obstet. Gynaecol. Res.33(4), 408–416 (2007).
   Web of Science ®Google Scholar
• Huang X, Huang H, Dong M, Yao Q, Wang H. Serum and placental interleukin-18 are elevated in preeclampsia. J. Reprod. Immunol.65(1), 77–87 (2005).
   PubMed Web of Science ®Google Scholar
• Hayashi M, Ueda Y, Ohkura T, Inaba N. Interleukin-6 concentrations in the placenta and blood in normal pregnancies and preeclampsia. Hum. Metab. Res.37(7), 419–424 (2005).
   PubMed Web of Science ®Google Scholar
• Lockwood CJ, Yen CF, Basar M et al. Preeclampsia-related inflammatory cytokines regulate interleukin-6 expression in human decidual cells. Am. J. Pathol.172(6), 1571–1579 (2008).
   PubMed Web of Science ®Google Scholar
• Huang SJ, Schatz F, Masch R et al. Regulation of chemokine production in response to pro-inflammatory cytokines in first trimester decidual cells. J. Reprod. Immunol.72(1,2), 60–73 (2006).
   Google Scholar
• Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinase: structure, function, and biochemistry. Circ. Res.92(8), 827–839 (2003).
   PubMed Web of Science ®Google Scholar
• Galis ZS, Khatri JJ. Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ. Res.90(3), 251–262 (2002).
   PubMed Web of Science ®Google Scholar
• Jones RL, Findlay JK, Farnworth PG et al. Activin A and inhibin A differentially regulate human uterine matrix metalloproteinases: potential interactions during decidualization and trophoblast invasion. Endocrinology147(2), 724–732 (2006).
   PubMed Web of Science ®Google Scholar
• Raffetto JD, Khalil RA. Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease. Biochem. Pharmacol.75(2), 346–359 (2007).
   Google Scholar
• Sawicki G, Radomski MW, Winkler-Lowen B et al. Polarized release of matrix metalloproteinase-2 and -9 from cultured human placental syncytiotrophoblasts. Bio. Reprod.63(5), 1390–1395 (2000).
   PubMed Web of Science ®Google Scholar
• Staun-Ram E, Goldman S, Gabarin D, Shalev E. Expression and importance of matrix metalloproteinase 2 and 9 (MMP-2 and -9) in human trophoblast invasion. Reprod. Biol. Endocrinol.2, 59–71 (2004).
   PubMedGoogle Scholar
• Narumiya H, Zhang Y, Fernandez-Patron C, Guilbert LJ, Davidge ST. Matrix metalloproteinase-2 is elevated in the plasma of women with preeclampsia. Hypertens. Pregnancy20(2), 185–194 (2001).
   PubMed Web of Science ®Google Scholar
• Isaka K, Usuda S, Ito H et al. Expression and activity of matrix metalloproteinase 2 and 9 in human trophoblasts. Placenta24(1), 53–64 (2003).
   PubMed Web of Science ®Google Scholar
• De Jager CA, Linton EA, Spyropoulou I, Sargent IL, Redman CW. Matrix metalloprotease-9, placental syncytiotrophoblast and the endothelial dysfunction of pre-eclampsia. Placenta24(1), 84–91 (2003).
   PubMedGoogle Scholar
• Huisman MA, Timmer A, Zeinstra M et al. Matrix-metalloproteinase activity in first trimester placental bed biopsies in further complicated and uncomplicated pregnancies. Placenta25(4), 253–258 (2004).
   Google Scholar
• Falkowski PG, Katz ME, Milligan AJ et al. The rise of oxygen over the past 205 years and the evolution of large placental mammals. Science309(5744), 2202–2204 (2005).
   PubMed Web of Science ®Google Scholar
• Genbacev O, Zhou Y, Ludlow JW et al. Regulation of human placental development by oxygen tension. Science277(5332), 1669–1672 (1997).
   PubMed Web of Science ®Google Scholar
• Lee H, Park H, Kim YJ et al. Expression of lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) in human preeclamptic placenta: possible implications in the process of trophoblast apoptosis. Placenta26(2–3), 226–233 (2005).
   PubMed Web of Science ®Google Scholar
• Ishioka S, Ezaka Y, Umemura K, Hayashi T, Endo T, Saito T. Proteomic analysis of mechanisms of hypoxia-induced apoptosis in trophoblastic cells. Int. J. Med. Sci.4(1), 36–44 (2007).
   Google Scholar
• Rajakumar A, Conrad KP. Expression, ontogeny, and regulation of hypoxia-inducible transcription factors in the human placenta. Biol. Reprod.63(2), 559–569 (2000).
   PubMed Web of Science ®Google Scholar
• Semenza GL. HIF-1 and mechanisms of hypoxia sensing. Curr. Opin. Cell Biol.13(2), 167–171 (2001).
   PubMed Web of Science ®Google Scholar
• Caniggia I, Mostachfi H, Winter J et al. Hypoxia-inducible factor-1 mediates the biological effects of oxygen on human trophoblast differentiation through TGF-β(3). J. Clin. Invest.105(5), 577–587 (2000).
   PubMed Web of Science ®Google Scholar
• Hayashi M, Sakata M, Takeda T et al. Induction of glucose transporter 1 expression through hypoxia-inducible factor 1α under hypoxic conditions in trophoblast-derived cells. J. Endocrinol.183(1), 145–154 (2004).
   Google Scholar
• Iwagaki S, Yokoyama Y, Tang L, Takahashi Y, Nakagawa Y, Tamaya T. Augmentation of leptin and hypoxia-inducible factor 1 mRNAs in the preeclamptic placenta. Gynecol. Endocrinol.18(5), 263–268 (2004).
   PubMed Web of Science ®Google Scholar
• Rajakumar A, Doty K, Daftary A et al. Impaired oxygen-dependent reduction of HIF-1α and -2α proteins in preeclamptic placentae. Placenta24(2–3), 199–208 (2003).
   PubMed Web of Science ®Google Scholar
• Baumann MU, Zamudio S, Illsley NP. Hypoxic upregulation of glucose transporters in BeWo choriocarcinoma cells is mediated by hypoxia-inducible factor-1. Am. J. Physiol. Cell Physiol.293(1), 477–485 (2007).
   PubMedGoogle Scholar
• Biondi C, Pavan B, Lunghi L et al. The role and modulation of the oxidative balance in pregnancy. Curr. Pharm. Des.11(16), 2075–2089 (2005).
   PubMed Web of Science ®Google Scholar
• Pavan L, Tsatsaris V, Hermouet A, Therond P, Evain-Brion D, Fournier T. Oxidized low-density lipoproteins inhibit trophoblastic cell invasion. J. Clin. Endocrinol. Metab.89(4), 1969–1972 (2004).
   Google Scholar
• Vanderlelie J, Venardos K, Clifton VL, Gude NM, Clarke FM, Perkins AV. Increased biological oxidation and reduced anti-oxidant enzyme activity in pre-eclamptic placentae. Placenta26(1), 53–58 (2005).
   PubMed Web of Science ®Google Scholar
• Myatt L, Rosenfield RB, Eis AL, Brockman DE, Greer I, Lyall F. Nitrotyrosine residues in placenta: evidence of peroxynitrite formation and action. Hypertension28(3), 488–493 (1996).
   PubMed Web of Science ®Google Scholar
• Chekir C, Nakatsuka M, Noguchi S et al. Accumulation of advanced glycation end products in women with preeclampsia: possible involvement of placental oxidative and nitrative stress. Placenta27(2–3), 225–233 (2006).
   PubMed Web of Science ®Google Scholar
• Takagi Y, Nikaido T, Toki T et al. Levels of oxidative stress and redox-related molecules in the placenta in preeclampsia and fetal growth restriction. Virchows Arch.444(1), 49–55 (2004).
   PubMed Web of Science ®Google Scholar
• Santoso DI, Rogers P, Wallace EM, Manuelpillai U, Walker D, Subakir SB. Localization of indoleamine 2,3-dioxygenase and 4-hydroxynonenal in normal and pre-eclamptic placentae. Placenta23(5), 373–379 (2002).
   Google Scholar
• Borrego-Diaz E, Rosales JC, Proverbio T et al. Effect of placental hypoxia on the plasma membrane Ca-ATPase (PMCA) activity and the level of lipid peroxidation of syncytiotrophoblast and red blood cell ghosts. Placenta29(1), 44–50 (2008).
   Google Scholar
• Gu Y, Burlison SA, Wang Y. PAF levels and PAF-AH activities in placentas from normal and preeclamptic pregnancies. Placenta27(6–7), 744–749 (2006).
   PubMed Web of Science ®Google Scholar
• Sawicki G, Dakour J, Morrish DW. Functional proteomics of neurokinin B in the placenta indicates a novel role in regulating cytotrophoblast antioxidant defence. Proteomics3(10), 2044–2051 (2003).
   PubMedGoogle Scholar
• Cindrova-Davies T, Spasic-Boskovic O, Jauniaux E, Charnock-Jones DS, Burton GJ. Nuclear factor-B, p38, and stress-activated protein kinase mitogen-activated protein kinase signaling pathways regulate proinflammatory cytokines and apoptosis in human placental explants in response to oxidative stress. Am. J. Pathol.170(5), 1511–1520 (2007).
   PubMed Web of Science ®Google Scholar
• Poston L, Briley AL, Seed PT, Kelly FJ, Shennan AH. Vitamins in Pre-eclampsia (VIP) Trial Consortium. Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): randomized placebo-controlled trial. Lancet367(9517), 1145–1154 (2006).
   PubMed Web of Science ®Google Scholar
• Campbell S, Park JH, Rowe J, Seeho SK, Morris JM, Gallery ED. Chorionic villus sampling as a source of trophoblasts. Placenta28(11–12), 1118–1122 (2007).
   PubMedGoogle Scholar
• Kalionis B, Moses E. Advanced molecular techniques in pregnancy research: proteomics and genomics – a workshop report. Placenta17(Suppl. A), S119–S122 (2003).
   Google Scholar
• Toft JH, Lian IA, Tarca AL et al. Whole-genome microarray and targeted analysis of angiogenesis-regulating gene expression (ENG, FLT1, VEGF, PlGF) in placentas from pre-eclamptic and small-for-gestational-age pregnancies. J. Matern. Fetal Neontal. Med.21(4), 267–273 (2008).
   PubMed Web of Science ®Google Scholar
• van Dijk M, Mulders J, Poutsma A et al. Maternal segregation of the Dutch preeclampsia locus at 10q22 with a new member of the winged helix gene family. Nat. Genet.37(5), 514–519 (2005).
   PubMed Web of Science ®Google Scholar
• Kivinen K, Peterson H, Hiltunen L et al. Evaluation of STOX1 as a preeclampsia candidate gene in a population-wide sample. Eur. J. Hum. Genet.15(4), 494–497 (2007).
   PubMed Web of Science ®Google Scholar
• Bainbridge SA, Belkacemi L, Dickinson M et al. Carbon monoxide inhibits hypoxia/reoxygenation-induced apoptosis and secondary necrosis in syncytiotrophoblast. Am. J. Pathol.169(3), 774–783 (2006).
   PubMedGoogle Scholar
• Belkacemi L, Bainbridge SA, Dickinson MA et al. Glyceryl trinitrate inhibits hypoxia-reoxygenation-induced apoptosis in the syncytiotrophoblast of the human placenta. Am. J. Pathol.170(3), 909–920 (2007).
   PubMed Web of Science ®Google Scholar